Growth Metrics

Nutex Health (NUTX) Cash from Discontinued Operations (2016 - 2017)

Nutex Health (NUTX) has disclosed Cash from Discontinued Operations for 5 consecutive years, with 8655.0 as the latest value for Q4 2017.

  • For Q4 2017, Cash from Discontinued Operations rose 15.47% year-over-year to 8655.0; the TTM value through Mar 2019 reached 8655.0, down 3491.29%, while the annual FY2017 figure was 9216.0, 93.03% up from the prior year.
  • Cash from Discontinued Operations hit 8655.0 in Q4 2017 for Nutex Health, down from 819.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 618246.0 in Q2 2014 and bottomed at 269436.0 in Q1 2016.
  • Average Cash from Discontinued Operations over 4 years is 64745.23, with a median of 819.0 recorded in 2017.
  • Year-over-year, Cash from Discontinued Operations soared 6282.74% in 2015 and then crashed 103.06% in 2016.
  • Nutex Health's Cash from Discontinued Operations stood at 5417.0 in 2014, then skyrocketed by 6282.74% to 334919.0 in 2015, then plummeted by 103.06% to 10239.0 in 2016, then rose by 15.47% to 8655.0 in 2017.
  • According to Business Quant data, Cash from Discontinued Operations over the past three periods came in at 8655.0, 819.0, and 9233.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.